BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35814825)

  • 21. Establishment and preliminary characterization of human malignant mesothelioma cell lines.
    de Cupis A; Pirani P; Favoni RE
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):188-92. PubMed ID: 9689807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.
    Masachika E; Kanno T; Nakano T; Gotoh A; Nishizaki T
    Anticancer Res; 2013 Mar; 33(3):887-94. PubMed ID: 23482758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy.
    Borchert S; Suckrau PM; Wessolly M; Mairinger E; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Walter RFH; Mairinger FD
    J Oncol; 2019; 2019():2902985. PubMed ID: 31929796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells.
    Menale C; Piccolo MT; Favicchia I; Aruta MG; Baldi A; Nicolucci C; Barba V; Mita DG; Crispi S; Diano N
    Pharm Res; 2015 Feb; 32(2):362-74. PubMed ID: 25092068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
    Mathilakathu A; Wessolly M; Mairinger E; Uebner H; Kreidt D; Brcic L; Steinborn J; Greimelmaier K; Wohlschlaeger J; Schmid KW; Mairinger FD; Borchert S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome size and chromosomes in marine sponges [Suberites Domuncula, Geodia Cydonium].
    Imsiecke G; Custodio M; Borojevic R; Steffen R; Moustafa MA; Müller WE
    Cell Biol Int; 1995 Dec; 19(12):995-1000. PubMed ID: 9721624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells.
    Lee YJ; Lee YJ; Im JH; Won SY; Kim YB; Cho MK; Nam HS; Choi YJ; Lee SH
    Food Chem Toxicol; 2013 Feb; 52():61-8. PubMed ID: 23146690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of Cell Death in Mesothelioma Cells by Magnetite Nanoparticles.
    Matsuda S; Hitsuji A; Nakanishi T; Zhang H; Tanaka A; Matsuda H; Osaka T
    ACS Biomater Sci Eng; 2015 Aug; 1(8):632-638. PubMed ID: 33435086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the embryonic lethal abnormal vision-like protein HuR in human mesothelioma: association with cyclooxygenase-2 and prognosis.
    Stoppoloni D; Cardillo I; Verdina A; Vincenzi B; Menegozzo S; Santini M; Sacchi A; Baldi A; Galati R
    Cancer; 2008 Nov; 113(10):2761-9. PubMed ID: 18831511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of an Aquaculture of Sponges for the Sustainable Production of Bioactive Metabolites in Open Systems: Example, Geodia cydonium.
    Müller WE; Wimmer W; Schatton W; Böhm M; Batel R; Filic Z
    Mar Biotechnol (NY); 1999 Nov; 1(6):569-579. PubMed ID: 10612682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [microRNA-30d can inhibit the proliferation, migration and invasion of human mesothelial cell MSTO-211H].
    Yuan XY; Zhang FF; Huang YL; Jia ZY; Ju L; Xiao Y; Xia HL; Gao YN; Yu M; Yu M; Zhang X; Zhu LJ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):99-104. PubMed ID: 33691362
    [No Abstract]   [Full Text] [Related]  

  • 32. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
    Chae JI; Jeon YJ; Shim JH
    Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
    Dell'Anno I; Martin SA; Barbarino M; Melani A; Silvestri R; Bottaro M; Paolicchi E; Corrado A; Cipollini M; Melaiu O; Giordano A; Luzzi L; Gemignani F; Landi S
    Invest New Drugs; 2021 Jun; 39(3):644-657. PubMed ID: 33300108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential multidrug resistance gene POHL: an ecologically relevant indicator in marine sponges.
    Krasko A; Kurelec B; Batel R; Müller IM; Müller WE
    Environ Toxicol Chem; 2001 Jan; 20(1):198-204. PubMed ID: 11351409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diarachidonoylphosphoethanolamine induces necrosis/necroptosis of malignant pleural mesothelioma cells.
    Kaku Y; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
    Cell Signal; 2015 Sep; 27(9):1713-9. PubMed ID: 26004138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of PPAR-γ agonist pioglitazone on the prolifeiration of malignant nesothelionma cells induced by HMGB1].
    Wang YB; Shen W; Gan YH; Zou J; Zhang Y; Zhu LJ; Ju L; Jiang ZQ; Ying SB
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Sep; 39(9):641-647. PubMed ID: 34624942
    [No Abstract]   [Full Text] [Related]  

  • 38. COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.
    O'Kane SL; Eagle GL; Greenman J; Lind MJ; Cawkwell L
    Lung Cancer; 2010 Feb; 67(2):160-5. PubMed ID: 19450893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.
    Di Meo F; Filosa S; Madonna M; Giello G; Di Pardo A; Maglione V; Baldi A; Crispi S
    J Exp Clin Cancer Res; 2019 Aug; 38(1):360. PubMed ID: 31419989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma.
    Oguh-Olayinka L; Agarwal V; Ranatunge D; Campbell A; Laufer S; Cawkwell L; Lind MJ
    Pathol Oncol Res; 2020 Apr; 26(2):985-995. PubMed ID: 30941737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.